Literature DB >> 10592068

46, XY, del (3) (pter-->p25) syndrome: further delineation of the clinical phenotype.

D Benini1, L Vino, S Vecchini, V Fanos.   

Abstract

A boy with monosomy for the distal part of the short arm of chromosome 3 is described. The clinical features this patient has in common with the previously reported cases include pre- and post-natal growth delay, microcephaly, craniofacial dysmorphism and mental retardation. In addition, minor abnormalities not previously reported were observed, such as snapping thumbs, dorsiflected big toes, connecting anterior and posterior fontanelles at birth, nasolacrimal duct stenosis and double urethral meatus. Conclusion These five new clinical findings may help in further delineation of the syndrome and allow its early recognition. A complete revision of clinical findings published in literature is reported.

Entities:  

Mesh:

Year:  1999        PMID: 10592068     DOI: 10.1007/s004310051256

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  3 in total

1.  3p-- syndrome defines a hearing loss locus in 3p25.3.

Authors:  Brendan J McCullough; Joe C Adams; Dustin J Shilling; M Patrick Feeney; Kathleen C Y Sie; Bruce L Tempel
Journal:  Hear Res       Date:  2007-01-08       Impact factor: 3.208

Review 2.  Chromosome rearrangements in cornelia de Lange syndrome (CdLS): report of a der(3)t(3;12)(p25.3;p13.3) in two half sibs with features of CdLS and review of reported CdLS cases with chromosome rearrangements.

Authors:  Cheryl DeScipio; Maninder Kaur; Dinah Yaeger; Jeffrey W Innis; Nancy B Spinner; Laird G Jackson; Ian D Krantz
Journal:  Am J Med Genet A       Date:  2005-09-01       Impact factor: 2.802

3.  Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.

Authors:  Thomas Fernandez; Thomas Morgan; Nicole Davis; Ami Klin; Ashley Morris; Anita Farhi; Richard P Lifton; Matthew W State
Journal:  Am J Hum Genet       Date:  2004-04-21       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.